Dr. Martens (LON:DOCS) Stock Price Down 9.6% – Should You Sell?

Dr. Martens plc (LON:DOCSGet Free Report) was down 9.6% during trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares were traded during trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Analyst Upgrades and Downgrades

Separately, Peel Hunt reiterated a “buy” rating on shares of Dr. Martens in a research note on Thursday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of GBX 6,000.

Read Our Latest Stock Report on DOCS

Dr. Martens Stock Down 9.6%

The firm’s 50-day moving average price is GBX 90.30 and its two-hundred day moving average price is GBX 80.31. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The firm has a market cap of £713.15 million, a PE ratio of 147.60, a P/E/G ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCSGet Free Report) last announced its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Buying and Selling

In other Dr. Martens news, insider Giles Wilson purchased 105,838 shares of Dr. Martens stock in a transaction that occurred on Monday, September 1st. The stock was purchased at an average price of GBX 91 per share, for a total transaction of £96,312.58. Also, insider Ije Nwokori sold 298,675 shares of Dr. Martens stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total transaction of £268,807.50. Over the last 90 days, insiders have bought 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. Company insiders own 2.80% of the company’s stock.

Dr. Martens Company Profile

(Get Free Report)

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

Featured Stories

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.